These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 32766134)

  • 1. Development and Validation of a Radiomics Nomogram Based on
    Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():1042. PubMed ID: 32766134
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of
    Yang B; Ji H; Zhong J; Ma L; Zhong J; Dong H; Zhou C; Duan S; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():567160. PubMed ID: 33262942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer.
    Jia T; Lv Q; Cai X; Ge S; Sang S; Zhang B; Yu C; Deng S
    Front Oncol; 2023; 13():1210125. PubMed ID: 37576897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of
    Song Y; Tian Y; Lu X; Chen G; Lv X
    Med Phys; 2024 Jul; 51(7):4907-4921. PubMed ID: 38252704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
    Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomic signature of
    Jiang Y; Yuan Q; Lv W; Xi S; Huang W; Sun Z; Chen H; Zhao L; Liu W; Hu Y; Lu L; Ma J; Li T; Yu J; Wang Q; Li G
    Theranostics; 2018; 8(21):5915-5928. PubMed ID: 30613271
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
    Front Oncol; 2022; 12():911168. PubMed ID: 36003788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning based on clinico-biological features integrated
    Ren C; Zhang J; Qi M; Zhang J; Zhang Y; Song S; Sun Y; Cheng J
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1538-1549. PubMed ID: 33057772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Nomogram Based on
    Yang X; Liu J; Lu X; Kan Y; Wang W; Zhang S; Liu L; Zhang H; Li J; Yang J
    Front Med (Lausanne); 2021; 8():792677. PubMed ID: 35004761
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and Validation of a
    Ouyang ML; Wang YR; Deng QS; Zhu YF; Zhao ZH; Wang L; Wang LX; Tang K
    Front Oncol; 2021; 11():710909. PubMed ID: 34568038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a [
    Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K
    Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative prediction of lymph node metastasis in colorectal cancer using
    Wang Y; Zhao H; Fu P; Tian L; Su Y; Lyu Z; Gu W; Wang Y; Liu S; Wang X; Zheng H; Du J; Zhang R
    Med Phys; 2024 May; ():. PubMed ID: 38801340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of
    Ma J; Guo D; Miao W; Wang Y; Yan L; Wu F; Zhang C; Zhang R; Zuo P; Yang G; Wang Z
    Abdom Radiol (NY); 2022 Apr; 47(4):1244-1254. PubMed ID: 35218381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of an
    Wang H; Zhao S; Li L; Tian R
    Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
    Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
    Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A PET/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer.
    Xie Y; Zhao H; Guo Y; Meng F; Liu X; Zhang Y; Huai X; Wong Q; Fu Y; Zhang H
    Eur Radiol; 2021 Aug; 31(8):6030-6038. PubMed ID: 33560457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT radiomics nomogram predicts pathological response after induced chemotherapy and overall survival in patients with advanced laryngeal cancer: A single-center retrospective study.
    Kang C; Sun P; Yang R; Zhang C; Ning W; Liu H
    Front Oncol; 2023; 13():1094768. PubMed ID: 37064100
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X
    Front Oncol; 2023; 13():1149791. PubMed ID: 36969043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.